<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>etoposide</title><link>http://www.unboundmedicine.com/medline/ebm/research/etoposide</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>[A case of metachronous testicular tumor developing seven years after complete remission of retroperitoneal extragonadal germ cell tumor.]</title><link>http://www.unboundmedicine.com/medline/ebm/record/19926951/full_citation/[A_case_of_metachronous_testicular_tumor_developing_seven_years_after_complete_remission_of_retroperitoneal_extragonadal_germ_cell_tumor_]</link><description>Kawamura N, Yamamoto K, Yoshioka I, et al. <br/><span class="title">[A case of metachronous testicular tumor developing seven years after complete remission of retroperitoneal extragonadal germ cell tumor.] [JOURNAL ARTICLE]</span><br/><span class="source" title="Hinyokika kiyo. Acta urologica Japonica">Hinyokika Kiyo 2009 Oct; 55(10):635-638.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19926951/abstract/[A_case_of_metachronous_testicular_tumor_developing_seven_years_after_complete_remission_of_retroperitoneal_extragonadal_germ_cell_tumor_]">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19926951/full_citation/[A_case_of_metachronous_testicular_tumor_developing_seven_years_after_complete_remission_of_retroperitoneal_extragonadal_germ_cell_tumor_]">Full Citation</a></description></item><item><title>VNCOP-B plus rituximab therapy in elderly patients with aggressive B-cell non-Hodgkin lymphoma: A multicenter experience.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19926148/full_citation/VNCOP_B_plus_rituximab_therapy_in_elderly_patients_with_aggressive_B_cell_non_Hodgkin_lymphoma:_A_multicenter_experience_</link><description>Ishii K, Urase F, Nagare Y, et al. <br/><span class="title">VNCOP-B plus rituximab therapy in elderly patients with aggressive B-cell non-Hodgkin lymphoma: A multicenter experience. [JOURNAL ARTICLE]</span><br/><span class="source" title="Archives of gerontology and geriatrics">Arch Gerontol Geriatr 2009 Nov 17.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19926148/abstract/VNCOP_B_plus_rituximab_therapy_in_elderly_patients_with_aggressive_B_cell_non_Hodgkin_lymphoma:_A_multicenter_experience_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19926148/full_citation/VNCOP_B_plus_rituximab_therapy_in_elderly_patients_with_aggressive_B_cell_non_Hodgkin_lymphoma:_A_multicenter_experience_">Full Citation</a></description></item><item><title>Advanced adult esthesioneuroblastoma successfully treated with cisplatin and etoposide alternated with doxorubicin, ifosfamide and vincristine.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19924514/full_citation/Advanced_adult_esthesioneuroblastoma_successfully_treated_with_cisplatin_and_etoposide_alternated_with_doxorubicin_ifosfamide_and_vincristine_</link><description>Turano S, Mastroianni C, Manfredi C, et al. <br/><span class="title">Advanced adult esthesioneuroblastoma successfully treated with cisplatin and etoposide alternated with doxorubicin, ifosfamide and vincristine. [JOURNAL ARTICLE]</span><br/><span class="source" title="Journal of neuro-oncology">J Neurooncol 2009 Nov 19.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19924514/abstract/Advanced_adult_esthesioneuroblastoma_successfully_treated_with_cisplatin_and_etoposide_alternated_with_doxorubicin_ifosfamide_and_vincristine_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19924514/full_citation/Advanced_adult_esthesioneuroblastoma_successfully_treated_with_cisplatin_and_etoposide_alternated_with_doxorubicin_ifosfamide_and_vincristine_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19924514/Advanced_adult_esthesioneuroblastoma_successfully_treated_with_cisplatin_and_etoposide_alternated_with_doxorubicin_ifosfamide_and_vincristine_">Find Related Articles</a> </description></item><item><title>Current status of chemotherapy in risk-adapted management for metastatic testicular germ cell cancer.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19922501/full_citation/Current_status_of_chemotherapy_in_risk_adapted_management_for_metastatic_testicular_germ_cell_cancer_</link><description>Kawai K, Akaza H <br/><span class="title">Current status of chemotherapy in risk-adapted management for metastatic testicular germ cell cancer. [JOURNAL ARTICLE]</span><br/><span class="source" title="Cancer science">Cancer Sci 2009 Sep 26.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19922501/abstract/Current_status_of_chemotherapy_in_risk_adapted_management_for_metastatic_testicular_germ_cell_cancer_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19922501/full_citation/Current_status_of_chemotherapy_in_risk_adapted_management_for_metastatic_testicular_germ_cell_cancer_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19922501/Current_status_of_chemotherapy_in_risk_adapted_management_for_metastatic_testicular_germ_cell_cancer_">Find Related Articles</a> </description></item><item><title>Tissue factor mediates the HGF/Met-induced anti-apoptotic pathway in DAOY medulloblastoma cells.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19921488/full_citation/Tissue_factor_mediates_the_HGF/Met_induced_anti_apoptotic_pathway_in_DAOY_medulloblastoma_cells_</link><description>Provençal M, Berger-Thibault N, Labbé D, et al. <br/><span class="title">Tissue factor mediates the HGF/Met-induced anti-apoptotic pathway in DAOY medulloblastoma cells. [JOURNAL ARTICLE]</span><br/><span class="source" title="Journal of neuro-oncology">J Neurooncol 2009 Nov 18.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19921488/abstract/Tissue_factor_mediates_the_HGF/Met_induced_anti_apoptotic_pathway_in_DAOY_medulloblastoma_cells_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19921488/full_citation/Tissue_factor_mediates_the_HGF/Met_induced_anti_apoptotic_pathway_in_DAOY_medulloblastoma_cells_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19921488/Tissue_factor_mediates_the_HGF/Met_induced_anti_apoptotic_pathway_in_DAOY_medulloblastoma_cells_">Find Related Articles</a> </description></item><item><title>Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II study.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19920819/full_citation/Metronomic_chemotherapy_with_daily_oral_etoposide_plus_bevacizumab_for_recurrent_malignant_glioma:_a_phase_II_study_</link><description>Reardon DA, Desjardins A, Vredenburgh JJ, et al. <br/><span class="title">Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II study. [JOURNAL ARTICLE]</span><br/><span class="source" title="British journal of cancer">Br J Cancer 2009 Nov 17.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19920819/abstract/Metronomic_chemotherapy_with_daily_oral_etoposide_plus_bevacizumab_for_recurrent_malignant_glioma:_a_phase_II_study_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19920819/full_citation/Metronomic_chemotherapy_with_daily_oral_etoposide_plus_bevacizumab_for_recurrent_malignant_glioma:_a_phase_II_study_">Full Citation</a></description></item><item><title>[Complete Remission with FLEP Chemotherapy for Multiple Liver Metastasis from Alpha-Fetoprotein-Producing Gastric Cancer-Report of a Case.]</title><link>http://www.unboundmedicine.com/medline/ebm/record/19920393/full_citation/[Complete_Remission_with_FLEP_Chemotherapy_for_Multiple_Liver_Metastasis_from_Alpha_Fetoprotein_Producing_Gastric_Cancer_Report_of_a_Case_]</link><description>Takahashi T, Kochi M, Kanamori N, et al. <br/><span class="title">[Complete Remission with FLEP Chemotherapy for Multiple Liver Metastasis from Alpha-Fetoprotein-Producing Gastric Cancer-Report of a Case.] [JOURNAL ARTICLE]</span><br/><span class="source" title="Gan to kagaku ryoho. Cancer &amp; chemotherapy">Gan To Kagaku Ryoho 2009 Nov; 36(11):1885-1888.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19920393/abstract/[Complete_Remission_with_FLEP_Chemotherapy_for_Multiple_Liver_Metastasis_from_Alpha_Fetoprotein_Producing_Gastric_Cancer_Report_of_a_Case_]">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19920393/full_citation/[Complete_Remission_with_FLEP_Chemotherapy_for_Multiple_Liver_Metastasis_from_Alpha_Fetoprotein_Producing_Gastric_Cancer_Report_of_a_Case_]">Full Citation</a></description></item><item><title>[Chemotherapy-Induced Myelosuppression and Treatment Efficacy in Extensive-Stage Small Cell Lung Cancer.]</title><link>http://www.unboundmedicine.com/medline/ebm/record/19920385/full_citation/[Chemotherapy_Induced_Myelosuppression_and_Treatment_Efficacy_in_Extensive_Stage_Small_Cell_Lung_Cancer_]</link><description>Yashiki C, Hirose T, Okuda K, et al. <br/><span class="title">[Chemotherapy-Induced Myelosuppression and Treatment Efficacy in Extensive-Stage Small Cell Lung Cancer.] [JOURNAL ARTICLE]</span><br/><span class="source" title="Gan to kagaku ryoho. Cancer &amp; chemotherapy">Gan To Kagaku Ryoho 2009 Nov; 36(11):1839-1843.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19920385/abstract/[Chemotherapy_Induced_Myelosuppression_and_Treatment_Efficacy_in_Extensive_Stage_Small_Cell_Lung_Cancer_]">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19920385/full_citation/[Chemotherapy_Induced_Myelosuppression_and_Treatment_Efficacy_in_Extensive_Stage_Small_Cell_Lung_Cancer_]">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19920385/[Chemotherapy_Induced_Myelosuppression_and_Treatment_Efficacy_in_Extensive_Stage_Small_Cell_Lung_Cancer_]">Find Related Articles</a> </description></item><item><title>Randomized Trial and Pharmacokinetic Study of Pegfilgrastim versus Filgrastim after Dose-Intensive Chemotherapy in Young Adults and Children with Sarcomas.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19920107/full_citation/Randomized_Trial_and_Pharmacokinetic_Study_of_Pegfilgrastim_versus_Filgrastim_after_Dose_Intensive_Chemotherapy_in_Young_Adults_and_Children_with_Sarcomas_</link><description>Fox E, Widemann BC, Hawkins DS, et al. <br/><span class="title">Randomized Trial and Pharmacokinetic Study of Pegfilgrastim versus Filgrastim after Dose-Intensive Chemotherapy in Young Adults and Children with Sarcomas. [JOURNAL ARTICLE]</span><br/><span class="source" title="Clinical cancer research : an official journal of the American Association for Cancer Research">Clin Cancer Res 2009 Nov 17.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19920107/abstract/Randomized_Trial_and_Pharmacokinetic_Study_of_Pegfilgrastim_versus_Filgrastim_after_Dose_Intensive_Chemotherapy_in_Young_Adults_and_Children_with_Sarcomas_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19920107/full_citation/Randomized_Trial_and_Pharmacokinetic_Study_of_Pegfilgrastim_versus_Filgrastim_after_Dose_Intensive_Chemotherapy_in_Young_Adults_and_Children_with_Sarcomas_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19920107/Randomized_Trial_and_Pharmacokinetic_Study_of_Pegfilgrastim_versus_Filgrastim_after_Dose_Intensive_Chemotherapy_in_Young_Adults_and_Children_with_Sarcomas_">Find Related Articles</a> </description></item><item><title>Antioxidant-induced modification of INrf2 cysteine 151 and PKC-{delta}-mediated phosphorylation of Nrf2 serine 40 are both required for stabilization and nuclear translocation of Nrf2 and increased drug resistance.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19920073/full_citation/Antioxidant_induced_modification_of_INrf2_cysteine_151_and_PKC_{delta}_mediated_phosphorylation_of_Nrf2_serine_40_are_both_required_for_stabilization_and_nuclear_translocation_of_Nrf2_and_increased_drug_resistance_</link><description>Niture SK, Jain AK, Jaiswal AK <br/><span class="title">Antioxidant-induced modification of INrf2 cysteine 151 and PKC-{delta}-mediated phosphorylation of Nrf2 serine 40 are both required for stabilization and nuclear translocation of Nrf2 and increased drug resistance. [JOURNAL ARTICLE]</span><br/><span class="source" title="Journal of cell science">J Cell Sci 2009 Nov 17.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19920073/abstract/Antioxidant_induced_modification_of_INrf2_cysteine_151_and_PKC_{delta}_mediated_phosphorylation_of_Nrf2_serine_40_are_both_required_for_stabilization_and_nuclear_translocation_of_Nrf2_and_increased_drug_resistance_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19920073/full_citation/Antioxidant_induced_modification_of_INrf2_cysteine_151_and_PKC_{delta}_mediated_phosphorylation_of_Nrf2_serine_40_are_both_required_for_stabilization_and_nuclear_translocation_of_Nrf2_and_increased_drug_resistance_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19920073/Antioxidant_induced_modification_of_INrf2_cysteine_151_and_PKC_{delta}_mediated_phosphorylation_of_Nrf2_serine_40_are_both_required_for_stabilization_and_nuclear_translocation_of_Nrf2_and_increased_drug_resistance_">Find Related Articles</a> </description></item></channel></rss>